Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Sohani AR"" wg kryterium: Autor


Tytuł :
Epstein-barr virus-positive diffuse large B-cell lymphoma during therapy with alemtuzumab for T-cell prolymphocytic leukemia.
Autorzy :
Sohani AR
Ferry JA
Chang PS
Abramson JS
Pokaż więcej
Źródło :
Journal of Clinical Oncology; 2/10/2010, Vol. 28 Issue 5, pe69-72, 1p
Czasopismo naukowe
Tytuł :
Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations.
Autorzy :
Wilbur DC ()
Madi K ()
Colvin RB ()
Duncan LM ()
Faquin WC ()
Ferry JA ()
Frosch MP ()
Houser SL ()
Kradin RL ()
Lauwers GY ()
Louis DN ()
Mark EJ ()
Mino-Kenudson M ()
Misdraji J ()
Nielsen GP ()
Pitman MB ()
Rosenberg AE ()
Smith RN ()
Sohani AR ()
Stone JR ()
Pokaż więcej
Źródło :
Archives of Pathology & Laboratory Medicine. Dec2009, Vol. 133 Issue 12, p1949-1953. 5p.
URL :
47192845
Czasopismo naukowe
Tytuł :
Simultaneous Identification of Cell of Origin, Translocations, and Hotspot Mutations in Diffuse Large B-Cell Lymphoma Using a Single RNA-Sequencing Assay.
Autorzy :
Crotty R; Department of Pathology, Massachusetts General Hospital, Boston.
Hu K; Department of Pathology, Massachusetts General Hospital, Boston.
Stevenson K; Dana Farber Cancer Institute, Boston, MA.
Pontius MY; Department of Pathology, Massachusetts General Hospital, Boston.
Sohani AR; Department of Pathology, Massachusetts General Hospital, Boston.
Ryan RJH; Department of Pathology, University of Michigan Medical School, Ann Arbor.
Rueckert E; NanoString Technologies, Seattle, WA.
Brauer HA; NanoString Technologies, Seattle, WA.
Hudson B; NanoString Technologies, Seattle, WA.
Berlin AM; ArcherDx, Boulder, CO.
Rodenbaugh M; ArcherDx, Boulder, CO.
Licon A; ArcherDx, Boulder, CO.
Haimes J; ArcherDx, Boulder, CO.
Iafrate AJ; Department of Pathology, Massachusetts General Hospital, Boston.
Nardi V; Department of Pathology, Massachusetts General Hospital, Boston.
Louissaint A; Department of Pathology, Massachusetts General Hospital, Boston.
Pokaż więcej
Źródło :
American journal of clinical pathology [Am J Clin Pathol] 2021 Apr 26; Vol. 155 (5), pp. 748-754.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Case 11-2021: A 39-Year-Old Woman with Fever, Flank Pain, and Inguinal Lymphadenopathy.
Autorzy :
Charles RC; From the Departments of Medicine (R.C.C., A.M.N.), Radiology (M.S.), Pediatrics (A.M.N.), and Pathology (A.R.S.), Massachusetts General Hospital, and the Departments of Medicine (R.C.C., A.M.N.), Radiology (M.S.), Pediatrics (A.M.N.), and Pathology (A.R.S.), Harvard Medical School - both in Boston.
Sertic M; From the Departments of Medicine (R.C.C., A.M.N.), Radiology (M.S.), Pediatrics (A.M.N.), and Pathology (A.R.S.), Massachusetts General Hospital, and the Departments of Medicine (R.C.C., A.M.N.), Radiology (M.S.), Pediatrics (A.M.N.), and Pathology (A.R.S.), Harvard Medical School - both in Boston.
Neilan AM; From the Departments of Medicine (R.C.C., A.M.N.), Radiology (M.S.), Pediatrics (A.M.N.), and Pathology (A.R.S.), Massachusetts General Hospital, and the Departments of Medicine (R.C.C., A.M.N.), Radiology (M.S.), Pediatrics (A.M.N.), and Pathology (A.R.S.), Harvard Medical School - both in Boston.
Sohani AR; From the Departments of Medicine (R.C.C., A.M.N.), Radiology (M.S.), Pediatrics (A.M.N.), and Pathology (A.R.S.), Massachusetts General Hospital, and the Departments of Medicine (R.C.C., A.M.N.), Radiology (M.S.), Pediatrics (A.M.N.), and Pathology (A.R.S.), Harvard Medical School - both in Boston.
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Apr 15; Vol. 384 (15), pp. 1448-1456.
Typ publikacji :
Case Reports; Clinical Conference; Journal Article
MeSH Terms :
Bartonella henselae/*isolation & purification
Cat-Scratch Disease/*diagnosis
Lymph Nodes/*pathology
Lymphadenopathy/*pathology
Adult ; Animals ; Bartonella henselae/genetics ; Cat-Scratch Disease/complications ; Cat-Scratch Disease/transmission ; Cats ; Diagnosis, Differential ; Escherichia coli/isolation & purification ; Female ; Fever/etiology ; Flank Pain/etiology ; Humans ; Klebsiella pneumoniae/isolation & purification ; Lymphadenopathy/diagnostic imaging ; Lymphadenopathy/etiology ; Nausea/etiology ; Polymerase Chain Reaction ; Tomography, X-Ray Computed ; Travel ; Urine/microbiology ; Weight Loss
Czasopismo naukowe
Tytuł :
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.
Autorzy :
Ma MCJ; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Tadros S; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Bouska A; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE.
Heavican T; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE.
Yang H; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Deng Q; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Moore D; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE.
Akhter A; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB.
Hartert K; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE.
Jain N; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Showell J; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Ghosh S; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Street L; Section of Hematology, Department of Medicine, University of Calgary, Calgary, AB.
Davidson M; Section of Hematology, Department of Medicine, University of Calgary, Calgary, AB.
Carey C; Northern Institute for Research, Newcastle University, Newcastle upon Tyne, England.
Tobin J; Diamantina Institute, University of Queensland, QLD.
Perumal D; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.
Vose JM; Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE.
Lunning MA; Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE.
Sohani AR; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Chen BJ; Department of Pathology, University of Massachusetts Medical School, UMass Memorial Medical Center, Worcester, MA.
Buckley S; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE.
Nastoupil LJ; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Davis RE; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Westin JR; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Fowler NH; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Parekh S; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.
Gandhi M; Diamantina Institute, University of Queensland, QLD.
Neelapu S; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Stewart D; Section of Hematology, Department of Medicine, University of Calgary, Calgary, AB.
Bhalla K; Department of Pathology, Brigham and Womens Hospital, Boston, MA.
Iqbal J; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE.
Greiner T; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE.
Rodig SJ; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Mansoor A; Section of Hematology, Department of Medicine, University of Calgary, Calgary, AB.
Green MR; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for Cancer Epigenetics, University of Texas MD Anderson Cancer Center, Houston, TX. .
Pokaż więcej
Źródło :
Haematologica [Haematologica] 2021 Apr 01. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma.
Autorzy :
Griffin GK; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
Weirather JL; Department of Data Sciences and.
Roemer MGM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Lipschitz M; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
Kelley A; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
Chen PH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Gusenleitner D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Jeter E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Pak C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Gjini E; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
Chapuy B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology and Oncology, University Medical Center, Göttingen, Germany.
Rosenthal MH; Department of Imaging, Dana-Farber Cancer Institute, Boston, MA.
Xu J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Chen BJ; Department of Pathology, UMass Memorial Medical Center, Worcester, MA.
Sohani AR; Department of Pathology and.
Lovitch SB; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
Abramson JS; Center for Lymphoma, Massachusetts General Hospital, Boston, MA; and.
Ishizuka JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medical Oncology, Yale Cancer Center, New Haven, CT.
Kim AI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Fletcher CD; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
Neuberg D; Department of Data Sciences and.
Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Wright K; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
Ligon AH; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
Pokaż więcej
Źródło :
Blood [Blood] 2021 Mar 11; Vol. 137 (10), pp. 1353-1364.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Plasma cell myeloma: role of histopathology, immunophenotyping, and genetic testing.
Autorzy :
Fitzpatrick MJ; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, WRN 219, Boston, MA, 02114, USA.; Department of Pathology, Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.
Nardi V; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, WRN 219, Boston, MA, 02114, USA.; Department of Pathology, Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.
Sohani AR; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, WRN 219, Boston, MA, 02114, USA. .; Department of Pathology, Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA. .
Pokaż więcej
Źródło :
Skeletal radiology [Skeletal Radiol] 2021 Mar 09. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy.
Autorzy :
Sohani AR; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Maurer MJ; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
Giri S; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
Pitcher B; The University of Texas MD Anderson Cancer Center, Houston, TX.; Alliance Statistics and Data Center, Duke University, Durham, NC.
Chadburn A; Weill Cornell Medical College, New York, NY.
Said JW; UCLA Medical Center, Los Angeles, CA.
Bartlett NL; Washington University School of Medicine, St. Louis, MO.
Czuczman MS; Celgene, Summit, NJ.
Martin P; Weill Cornell Medical College, New York, NY.
Rosenbaum CA; Weill Cornell Medical College, New York, NY.
Jung SH; Alliance Statistics and Data Center, Duke University, Durham, NC.
Leonard JP; Weill Cornell Medical College, New York, NY.
Cheson BD; Medstar Georgetown University, Washington, DC.
Hsi ED; Cleveland Clinic, Cleveland, OH.
Pokaż więcej
Źródło :
The American journal of surgical pathology [Am J Surg Pathol] 2021 Mar 01; Vol. 45 (3), pp. 384-393.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
MeSH Terms :
Antigens, CD20/*analysis
Antineoplastic Agents, Immunological/*therapeutic use
Lymphoma, Follicular/*drug therapy
Rituximab/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/adverse effects ; Biomarkers, Tumor/analysis ; Clinical Trials as Topic ; Disease Progression ; Female ; Humans ; Immunohistochemistry ; Ki-67 Antigen/analysis ; Lymphoma, Follicular/immunology ; Lymphoma, Follicular/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Neprilysin/analysis ; Prospective Studies ; Proto-Oncogene Proteins c-bcl-6/analysis ; Recurrence ; Risk Assessment ; Risk Factors ; Rituximab/adverse effects ; Time Factors ; Treatment Outcome ; Tumor Microenvironment ; United States ; Young Adult
Czasopismo naukowe
Tytuł :
Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.
Autorzy :
Fitzpatrick MJ; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Sayed S; Department of Pathology, Aga Khan University Hospital, Nairobi, Kenya.
Moloo Z; Department of Pathology, Aga Khan University Hospital, Nairobi, Kenya.
Kayembe MKA; Botswana National Health Laboratory, Gaborone, Botswana.
Roberts DJ; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Pham TA; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Xi L; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Raffeld M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Louissaint A; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Sohani AR; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
American journal of clinical pathology [Am J Clin Pathol] 2021 Feb 02. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Improving Malignancy Detection Rates in Body Fluids Submitted to the Hematology Laboratory for Nucleated Cell Count and Differential: A Quality Improvement Study.
Autorzy :
Zhang ML; From the Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston (Zhang, Maglantay).
Maglantay RJ; From the Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston (Zhang, Maglantay).; the Department of Laboratory Medicine and Pathology, University of Alberta Hospital, Edmonton, Alberta, Canada (Maglantay).
Cunningham VL; the Department of Pathology, Massachusetts General Hospital, Boston (Cunningham, Goodwin, Feeney, Keefe).
Goodwin MT; the Department of Pathology, Massachusetts General Hospital, Boston (Cunningham, Goodwin, Feeney, Keefe).
Feeney MW; the Department of Pathology, Massachusetts General Hospital, Boston (Cunningham, Goodwin, Feeney, Keefe).
Keefe J; the Department of Pathology, Massachusetts General Hospital, Boston (Cunningham, Goodwin, Feeney, Keefe).
Tambouret RH; the Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston (Tambouret, Sohani).
Sohani AR; the Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston (Tambouret, Sohani).
Pokaż więcej
Źródło :
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2021 Feb 01; Vol. 145 (2), pp. 201-207.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Body Fluids/*cytology
Carcinoma/*diagnosis
Laboratories/*standards
Cytodiagnosis ; Erythroblasts/cytology ; Hematologic Tests ; Hematology ; Humans ; Quality Improvement ; Specimen Handling
Czasopismo naukowe
Tytuł :
Falling prey to a wolf in sheep's clothing: T and NK cell neoplasms with aberrant CD20 expression.
Autorzy :
Sohani AR; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St., WRN 219, Boston, MA, 02114, USA. .
Pokaż więcej
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2020 Dec; Vol. 477 (6), pp. 897-899. Date of Electronic Publication: 2020 Aug 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Peripheral blood morphologic findings in patients with COVID-19.
Autorzy :
Sadigh S; Pathology Department, Massachusetts General Hospital, Boston, Massachusetts, USA.
Massoth LR; Pathology Department, Massachusetts General Hospital, Boston, Massachusetts, USA.
Christensen BB; Pathology Department, Massachusetts General Hospital, Boston, Massachusetts, USA.
Stefely JA; Pathology Department, Massachusetts General Hospital, Boston, Massachusetts, USA.
Keefe J; Pathology Department, Massachusetts General Hospital, Boston, Massachusetts, USA.
Sohani AR; Pathology Department, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
International journal of laboratory hematology [Int J Lab Hematol] 2020 Dec; Vol. 42 (6), pp. e248-e251. Date of Electronic Publication: 2020 Jul 30.
Typ publikacji :
Letter
MeSH Terms :
Betacoronavirus*
Blood Cells/*ultrastructure
Coronavirus Infections/*blood
Pneumonia, Viral/*blood
Adult ; Aged ; Aged, 80 and over ; Blood Cell Count ; COVID-19 ; Cell Lineage ; Cell Size ; Coronavirus Infections/therapy ; Extracorporeal Membrane Oxygenation ; Female ; Hematopoiesis ; Humans ; Male ; Middle Aged ; Neutrophils/ultrastructure ; Pandemics ; Plasma Cells/ultrastructure ; Pneumonia, Viral/therapy ; SARS-CoV-2 ; Sensitivity and Specificity
Opinia redakcyjna
Tytuł :
Unusual inclusions in cerebrospinal fluid macrophages of spinal muscular atrophy patients treated with nusinersen.
Autorzy :
Machacek ME; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Gogakos T; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Fletcher MC; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Lunderville KA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Swoboda KJ; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Sohani AR; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Pokaż więcej
Źródło :
International journal of laboratory hematology [Int J Lab Hematol] 2020 Nov 17. Date of Electronic Publication: 2020 Nov 17.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Reply to M. Romero et al.
Autorzy :
Jaffe ES; Elaine S. Jaffe, MD, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Andrew L. Feldman, MD, Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN; Philippe Gaulard, MD, PhD, Departement de Pathologie, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France; Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Aliyah R. Sohani, MD, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Feldman AL; Elaine S. Jaffe, MD, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Andrew L. Feldman, MD, Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN; Philippe Gaulard, MD, PhD, Departement de Pathologie, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France; Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Aliyah R. Sohani, MD, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Gaulard P; Elaine S. Jaffe, MD, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Andrew L. Feldman, MD, Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN; Philippe Gaulard, MD, PhD, Departement de Pathologie, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France; Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Aliyah R. Sohani, MD, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Miranda RN; Elaine S. Jaffe, MD, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Andrew L. Feldman, MD, Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN; Philippe Gaulard, MD, PhD, Departement de Pathologie, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France; Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Aliyah R. Sohani, MD, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Sohani AR; Elaine S. Jaffe, MD, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Andrew L. Feldman, MD, Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN; Philippe Gaulard, MD, PhD, Departement de Pathologie, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France; Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Aliyah R. Sohani, MD, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Aug 20; Vol. 38 (24), pp. 2819-2820. Date of Electronic Publication: 2020 Jun 17.
Typ publikacji :
Letter; Comment
MeSH Terms :
Breast Implants*
Breast Neoplasms*
Lymphoma, Large-Cell, Anaplastic*
Humans
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies